A. D. J. Pearson

672 total citations
17 papers, 506 citations indexed

About

A. D. J. Pearson is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. D. J. Pearson has authored 17 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 5 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. D. J. Pearson's work include Neuroblastoma Research and Treatments (6 papers), Estrogen and related hormone effects (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). A. D. J. Pearson is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Estrogen and related hormone effects (4 papers) and Sarcoma Diagnosis and Treatment (3 papers). A. D. J. Pearson collaborates with scholars based in United Kingdom, Australia and Sweden. A. D. J. Pearson's co-authors include Simon Cotterill, Jon Pritchard, J. A. Kohler, A.B.M. Foot, Borghild Roald, John Imeson, A G McGuckin, L Price, I J Lewis and N Bown and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Leukemia.

In The Last Decade

A. D. J. Pearson

17 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. D. J. Pearson United Kingdom 11 273 220 114 104 66 17 506
Motoaki Chin Japan 16 99 0.4× 218 1.0× 86 0.8× 55 0.5× 82 1.2× 43 540
Mayumi Higashi Japan 15 213 0.8× 322 1.5× 101 0.9× 126 1.2× 25 0.4× 50 706
Beate Häberle Germany 18 221 0.8× 486 2.2× 254 2.2× 217 2.1× 74 1.1× 42 1.1k
V. Lapierre France 13 154 0.6× 128 0.6× 77 0.7× 49 0.5× 15 0.2× 28 452
T Hotta Japan 12 86 0.3× 143 0.7× 224 2.0× 71 0.7× 22 0.3× 55 574
J P Harpey France 9 57 0.2× 232 1.1× 84 0.7× 58 0.6× 24 0.4× 21 442
Joeffrey Chahine United States 12 244 0.9× 143 0.7× 371 3.3× 49 0.5× 43 0.7× 26 762
U. Hettmannsperger Germany 10 50 0.2× 107 0.5× 93 0.8× 111 1.1× 47 0.7× 15 429
E. Stanton Adkins United States 8 687 2.5× 455 2.1× 134 1.2× 242 2.3× 10 0.2× 13 895
G.A. Amos Burke United Kingdom 13 110 0.4× 141 0.6× 221 1.9× 71 0.7× 282 4.3× 37 601

Countries citing papers authored by A. D. J. Pearson

Since Specialization
Citations

This map shows the geographic impact of A. D. J. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. D. J. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. D. J. Pearson more than expected).

Fields of papers citing papers by A. D. J. Pearson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. D. J. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. D. J. Pearson. The network helps show where A. D. J. Pearson may publish in the future.

Co-authorship network of co-authors of A. D. J. Pearson

This figure shows the co-authorship network connecting the top 25 collaborators of A. D. J. Pearson. A scholar is included among the top collaborators of A. D. J. Pearson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. D. J. Pearson. A. D. J. Pearson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lovat, Penny E., Mark G. Dobson, Archie J. Malcolm, A. D. J. Pearson, & Christopher P.F. Redfern. (2001). Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells. Medical and Pediatric Oncology. 36(1). 135–138. 2 indexed citations
2.
Bailey, Simon, Andrew G. Hall, A. D. J. Pearson, & Christopher P.F. Redfern. (2001). The role of AP-1 in glucocorticoid resistance in leukaemia. Leukemia. 15(3). 391–397. 12 indexed citations
3.
Cotterill, Simon, A. D. J. Pearson, Jon Pritchard, et al.. (2000). Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992. European Journal of Cancer. 36(7). 901–908. 123 indexed citations
4.
Hewson, Quentin Campbell, Penny E. Lovat, Archie J. Malcolm, A. D. J. Pearson, & Christopher P.F. Redfern. (2000). Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells. Neuroscience Letters. 279(2). 113–116. 7 indexed citations
5.
Skinner, Roderick, et al.. (1998). Cisplatin dose rate as a risk factor for nephrotoxicity in children. British Journal of Cancer. 77(10). 1677–1682. 82 indexed citations
6.
George, Rani E., A G McGuckin, Nancy E. Kohl, et al.. (1997). Analysis of candidate gene co-amplification with MYCN in neuroblastoma. European Journal of Cancer. 33(12). 2037–2042. 27 indexed citations
7.
Lovat, Penny E., Helen Irving, Margherita Annicchiarico‐Petruzzelli, et al.. (1997). Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid. European Journal of Cancer. 33(12). 2075–2080. 34 indexed citations
8.
Łastowska, Maria, Simon Cotterill, A. D. J. Pearson, et al.. (1997). Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. European Journal of Cancer. 33(10). 1627–1633. 84 indexed citations
9.
Estlin, EJ, et al.. (1996). Phase I trials in paediatric oncology — the European perspective. Investigational New Drugs. 14(1). 23–32. 9 indexed citations
10.
Yule, S. Murray, Patrick Dawes, A J Malcolm, & A. D. J. Pearson. (1994). Occurrence of Seminoma and Dysgerminoma in Father and Daughter. Pediatric Hematology and Oncology. 11(2). 211–213. 4 indexed citations
11.
Bown, Nick, M M Reid, A J Malcolm, et al.. (1994). Cytogenetic abnormalities of small round cell tumours. Medical and Pediatric Oncology. 23(2). 124–129. 24 indexed citations
12.
Jaros, Evelyn, et al.. (1993). p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. British Journal of Cancer. 68(4). 801–807. 30 indexed citations
13.
Pearson, A. D. J., et al.. (1992). Comparison of saphenous versus jugular veins for central venous access in children with malignancy. Journal of Pediatric Surgery. 27(5). 609–611. 6 indexed citations
14.
Pearson, A. D. J., et al.. (1991). Choroidal involvement in lymphomatoid granulomatosis.. British Journal of Ophthalmology. 75(11). 688–689. 8 indexed citations
15.
Pinkerton, CR, JM Zucker, Olivier Hartmann, et al.. (1990). Short duration, high dose, alternating chemotherapy in metastatic neuroblastoma. (ENSG 3C induction regimen). British Journal of Cancer. 62(2). 319–323. 29 indexed citations
16.
Sviland, Lisbet, A. D. J. Pearson, Edmund J. Eastham, et al.. (1989). Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease. Newcastle Bone Marrow Transplant Group.. PubMed. 4(3). 233–8. 11 indexed citations
17.
Pearson, A. D. J., et al.. (1988). Intestinal permeability during chemotherapy for childhood tumours. European Journal of Pediatrics. 147(2). 123–127. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026